EPRX Annual SG&A
$5.39 M
+$2.33 M+76.00%
31 December 2023
Summary:
As of January 23, 2025, EPRX annual selling, general & administrative expenses is $5.39 million, with the most recent change of +$2.33 million (+76.00%) on December 31, 2023. During the last 3 years, it has risen by +$4.45 million (+469.28%). EPRX annual SG&A is now -23.90% below its all-time high of $7.09 million, reached on December 1, 2021.EPRX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPRX Quarterly SG&A
$2.22 M
-$359.70 K-13.93%
01 September 2024
Summary:
As of January 23, 2025, EPRX quarterly selling, general & administrative expenses is $2.22 million, with the most recent change of -$359.70 thousand (-13.93%) on September 1, 2024. Over the past year, it has dropped by -$359.70 thousand (-13.93%). EPRX quarterly SG&A is now -37.71% below its all-time high of $3.57 million, reached on March 1, 2021.EPRX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPRX TTM SG&A
-$458.09 M
-$33.23 M-7.82%
01 September 2024
Summary:
As of January 23, 2025, EPRX TTM selling, general & administrative expenses is -$458.09 million, with the most recent change of -$33.23 million (-7.82%) on September 1, 2024. Over the past year, it has dropped by -$467.29 million (-5078.88%). EPRX TTM SG&A is now -1167.78% below its all-time high of $9.56 million, reached on September 1, 2024.EPRX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPRX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +76.0% | -13.9% | -5078.9% |
| 3 y3 years | +469.3% | +79.9% | -6609.4% |
| 5 y5 years | -7.3% | +541.1% | -10000.0% |
EPRX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -23.9% | +76.0% | -13.9% | +222.6% | -114.2% | at low |
| 5 y | 5-year | -23.9% | +469.3% | -37.7% | +1079.5% | -1167.8% | at low |
| alltime | all time | -23.9% | +469.3% | -37.7% | +1079.5% | -1167.8% | at low |
Eupraxia Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.22 M(-13.9%) | $9.56 M(+3.9%) |
| June 2024 | - | $2.58 M(+2.6%) | $9.20 M(+7.7%) |
| Mar 2024 | - | $2.52 M(+12.6%) | $8.54 M(+17.2%) |
| Dec 2023 | $5.39 M(+76.0%) | $2.24 M(+20.0%) | $7.28 M(+11.8%) |
| Sept 2023 | - | $1.86 M(-3.1%) | $6.51 M(+22.0%) |
| June 2023 | - | $1.92 M(+52.4%) | $5.34 M(+23.2%) |
| Mar 2023 | - | $1.26 M(-13.9%) | $4.33 M(+3.2%) |
| Dec 2022 | $3.06 M(-56.8%) | - | - |
| Dec 2022 | - | $1.47 M(+112.6%) | $4.20 M(+5.8%) |
| Sept 2022 | - | $689.30 K(-24.9%) | $3.97 M(-10.6%) |
| June 2022 | - | $918.00 K(-18.5%) | $4.44 M(-3.4%) |
| Mar 2022 | - | $1.13 M(-8.8%) | $4.59 M(-34.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $7.09 M(+648.1%) | $1.24 M(+6.7%) | $7.04 M(+16.7%) |
| Sept 2021 | - | $1.16 M(+7.8%) | $6.03 M(+18.7%) |
| June 2021 | - | $1.07 M(-69.9%) | $5.08 M(+21.1%) |
| Mar 2021 | - | $3.57 M(+1472.4%) | $4.19 M(+331.8%) |
| Dec 2020 | $947.60 K(-58.3%) | $227.00 K(+8.7%) | $971.20 K(-24.3%) |
| Sept 2020 | - | $208.90 K(+10.8%) | $1.28 M(-24.1%) |
| June 2020 | - | $188.50 K(-45.6%) | $1.69 M(+12.5%) |
| Mar 2020 | - | $346.80 K(-35.7%) | $1.50 M(+30.0%) |
| Dec 2019 | $2.27 M(-61.0%) | $539.20 K(-12.6%) | $1.16 M(+87.4%) |
| Sept 2019 | - | $617.20 K | $617.20 K |
| Dec 2018 | $5.82 M(+344.0%) | - | - |
| Dec 2017 | $1.31 M | - | - |
FAQ
- What is Eupraxia Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals annual SG&A year-on-year change?
- What is Eupraxia Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals quarterly SG&A year-on-year change?
- What is Eupraxia Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals TTM SG&A year-on-year change?
What is Eupraxia Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of EPRX is $5.39 M
What is the all time high annual SG&A for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high annual selling, general & administrative expenses is $7.09 M
What is Eupraxia Pharmaceuticals annual SG&A year-on-year change?
Over the past year, EPRX annual selling, general & administrative expenses has changed by +$2.33 M (+76.00%)
What is Eupraxia Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of EPRX is $2.22 M
What is the all time high quarterly SG&A for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $3.57 M
What is Eupraxia Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, EPRX quarterly selling, general & administrative expenses has changed by -$359.70 K (-13.93%)
What is Eupraxia Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of EPRX is -$458.09 M
What is the all time high TTM SG&A for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high TTM selling, general & administrative expenses is $9.56 M
What is Eupraxia Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, EPRX TTM selling, general & administrative expenses has changed by -$467.29 M (-5078.88%)